Intraocular Mantle Cell Lymphoma of the Iris

被引:9
|
作者
Reid, Jonathan P. [1 ]
Puglis, Christie L. [2 ]
Slagle, William Scott [1 ,3 ]
机构
[1] Salem Vet Affairs Med Ctr, Salem, VA USA
[2] Wing Eyecare, Cincinnati, OH USA
[3] Virginia Tech Carilion Sch Med, Roanoke, VA USA
关键词
mantle cell lymphoma; non-Hodgkin lymphoma; uveitis; anisocoria; mutton-fat keratic precipitates; DIAGNOSIS; MASS;
D O I
10.1097/OPX.0000000000000218
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose Non-Hodgkin lymphoma (NHL) is a neoplastic process of the lymphatic system in which tumors develop from lymphocytes. The absence of Reed-Sternberg cells differentiates NHL from Hodgkin lymphoma (HL). Mantle cell lymphoma is a mature B-cell NHL, typically with an aggressive course. Manifestations of intraocular mantle cell lymphoma include anterior uveitis, morphologic changes to the uvea, vitritis, intraocular masses, as well as subretinal or choroidal infiltrates. Case Report A 71-year-old white man with known mantle cell lymphoma presents with recent-onset blurred vision in the left eye resulting from an atypical anterior chamber cellular reaction. Iris examination reveals topographic and morphologic atypia suggestive of neoplasia. He subsequently developed posterior cervical lymph node involvement indicating recurrence of his mantle cell lymphoma. He was restarted on chemotherapy and radiation. The iris and anterior chamber reaction responded to systemic oncological therapy. Conclusions Mantle cell lymphoma may present with ocular manifestations such as an anterior chamber cellular reaction and morphologic changes to the uvea. This case stresses the importance of seeking an etiology in any secondary or atypical uveitis.
引用
收藏
页码:S25 / S29
页数:5
相关论文
共 50 条
  • [1] Mantle cell lymphoma of the iris treated by ibrutinib
    De Gauzy, T. Sales
    Oberic, L.
    Fournie, P.
    Soler, V.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2018, 41 (10): : E501 - E502
  • [2] Ibrutinib for mantle cell lymphoma
    Tucker, David L.
    Rule, Simon A.
    FUTURE ONCOLOGY, 2016, 12 (04) : 477 - 491
  • [3] Candy Cane Hypopyon Secondary to Intraocular Mantle Cell Lymphoma: A Case Report
    Babiker, Fatima
    Zhou, Avery
    Rujkorakarn, Ploysai
    Philip, Andrew M.
    Valerio, Tate
    Massoudi, Yasmin
    Anesi, Stephen D.
    Foster, C. Stephen
    CASE REPORTS IN OPHTHALMOLOGY, 2024, 15 (01): : 833 - 840
  • [4] Blastoid variant of mantle cell lymphoma in palatine tonsil
    Valente, Vitor Bonetti
    de Castro, Tamara Fernandes
    Takamiya, Aline Satie
    Callestini, Renata
    Xavier-Junior, Jose Candido Caldeira
    Cortopassi, Gabriel Macedo
    Neto, Sebastiao Conrado
    Collado, Francisco Urbano
    Biasoli, Eder Ricardo
    Miyahara, Glauco Issamu
    Bernabe, Daniel Galera
    ORAL ONCOLOGY, 2021, 122
  • [5] Novel Agents in Mantle Cell Lymphoma
    Kumar, Anita
    CURRENT ONCOLOGY REPORTS, 2015, 17 (08)
  • [6] Watch and Wait in Mantle Cell Lymphoma
    Lee, Christina
    Martin, Peter
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2020, 34 (05) : 837 - 847
  • [7] Educational Case: Mantle Cell Lymphoma
    Mai, Brenda
    Saluja, Karan
    Hu, Zhihong
    Nguyen, Nghia D.
    Wahed, Amer
    Wang, Xiaohong Iris
    Chen, Lei
    ACADEMIC PATHOLOGY, 2020, 7
  • [8] Guideline for the management of mantle cell lymphoma
    McKay, Pamela
    Leach, Mike
    Jackson, Bob
    Robinson, Stephen
    Rule, Simon
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (01) : 46 - 62
  • [9] Emerging therapies in mantle cell lymphoma
    Hanel, Walter
    Epperla, Narendranath
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [10] Tackling Mantle Cell Lymphoma in Europe
    Horgan, Denis
    Walewski, Jan
    Aurer, Igor
    Visco, Carlo
    Gine, Eva
    Fetica, Bogdan
    Jerkeman, Mats
    Kozaric, Marta
    da Silva, Maria Gomes
    Dreyling, Martin
    HEALTHCARE, 2022, 10 (09)